Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03146507
Other study ID # AU03
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2017
Est. completion date September 1, 2022

Study information

Verified date November 2022
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The fetal heart plays a central role in the adaptive mechanisms for hypoxemia and placental insufficiency. Longitudinal data on the hemodynamic sequence of the natural history of fetal growth restriction show that the umbilical artery and middle cerebral artery are the first variables to become abnormal . These arterial Doppler abnormalities are followed by abnormalities in the right cardiac diastolic indices, followed by the right cardiac systolic indices, and finally by both left diastolic and systolic cardiac indices . Preserving the left systolic function as the last variable to become abnormal ensures an adequate left ventricular output , which supplies the cerebral and coronary circulations.This defence is contingent on the fetal cardiovascular system, which in late gestation adopts strategies to decrease oxygen consumption and redistribute the cardiac output away from peripheral vascular beds and towards essential circulations, such as those perfusing the brain. Adding cardiac Doppler may improve management of the IUGR fetus(intrauterine growth retardation), Doppler ultrasound is valuable in defining the degree of cardiovascular compromise in at-risk pregnancies. The severity of fetal blood flow redistribution shows the degree of fetal adaptation and provides information on how long the pregnancy can be continued safely. The aime of the study is assessment of cardiac output redistribution in fetal hypoxia by estimating relative right to left side cardiac output wich reflect cardiac sparing in (IUGR).


Recruitment information / eligibility

Status Completed
Enrollment 210
Est. completion date September 1, 2022
Est. primary completion date May 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 35 Years
Eligibility Inclusion Criteria: 1. Women aged 20-35 years. 2. Women with BMI from 20-30 kg/m2. 3. Pregnant women in singleton fetuses from 32 to 34 weeks gestation. 4. Women with late fetal growth restriction fetuses. It refers to an estimated fetal weight or abdominal circumference <10th centile. Those women had increased the resistant index (RI) in umbilical arteries above the 95th percentile at the time of recruitment (case group). 5. Normal pregnant women (control group). Exclusion Criteria: 1. Women with estimated fetal weight below the 5th or 3rd percentile. 2. Women with premature pre-labor rupture of membranes. 3. Women with antepartum hemorrhage 4. Women with fetal congenital anomalies. 5. Women with absent or reversed diastolic flow in the umbilical artery at the time of recruitment. 6. Women with preeclampsia or on anti-coagulant thereby. 7. Women who refused to participate in our study.

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
Ultrasound
ultrasound assessment of gestational age, amniotic fluid index, and fetal weight
Doppler ultrasound
Umbilical artery and Middle cerebral artery Doppler blood flow assesment
Fetal echocardiography
The cardiac output (ratio between right side cardiac outputs to left side cardiac output) was calculated

Locations

Country Name City State
Egypt Advanced Fetal Cair Unit - Assiut University Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary The relative cardiac output ratio (ratio between right side cardiac outputs to left side) cardiac output) at 32-34 weeks. 1 month
Secondary The relative cardiac output ratio at 34-36 weeks. 1 month
Secondary The pulsatility index in the umbilical artery and middle cerebral artery at 32-34 weeks 1 month
Secondary The pulsatility index in the umbilical artery and middle cerebral artery at 34-36 weeks 1 month
Secondary Middle cerebral artery pulsatility index to umbilical artery pulsatility index ratio 15 minutes
Secondary Time of delivery (weeks) 7 weeks
Secondary Birth weight (grams) 7 weeks
See also
  Status Clinical Trial Phase
Completed NCT02379728 - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth N/A
Active, not recruiting NCT00189007 - Antenatal Allopurinol During Fetal Hypoxia Phase 3
Recruiting NCT05681624 - Maternal Oxygen Supplementation for Intrauterine Resuscitation N/A
Completed NCT03108040 - Evaluation of Fetal Cardiac Function and Vascular Hemodynamics in Intrauterine Growth Restriction
Completed NCT02377817 - Halifax PrenaBelt Trial N/A
Active, not recruiting NCT02643108 - Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women N/A
Completed NCT02741284 - Oxygen for Intrauterine Resuscitation of Category II Fetal Heart Tracings N/A
Terminated NCT05147584 - Trans-abdominal Fetal Pulse Oximetry N/A
Recruiting NCT01533701 - Scalp Sampling for Fetal Surveillance N/A
Terminated NCT04437407 - UniSA BackOff! Study: Adelaide PrenaBelt Trial N/A
Not yet recruiting NCT03930277 - Intra-uterine Fetal Brain Activity Monitoring.
Recruiting NCT04876846 - Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity N/A
Recruiting NCT06405984 - Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE Early Phase 1
Suspended NCT04364308 - The Relationship Between Umbilical Cord ph and Feto-maternal Doppler Studies in Scheduled Nonlaboring Term Singleton Caesarean Deliveries